Conversely our adjustment for under-testing (adjustment factor 2) could over-estimate true incidence since it is possible that children who are not tested represent a different clinical spectrum of disease, making invalid the assumption that the proportion of influenza positive cases in the untested group is the same as in the find more tested group. We also did not make any adjustments for children readmitted to the same or different HA hospital with the same influenza infection and for possible nosocomial infections which could have led to an over-estimation of incidence. It is also likely that children with nosocomial influenza will have a longer length of stay, emphasising

that length of stay does not consistently reflect disease severity. We have also assumed that the adjustment factors derived from one institution, PWH, can be applied uniformly across all the HA hospitals, and that these factors are stable over time. Although PWH is one of the largest HA hospitals accounting for about 10% of all the public hospital paediatric admissions, it is possible that there may be differences in clinical practices, admission policies and laboratory services between PWH and other HA hospitals and also over time. Estimates of the incidence of influenza

that requires hospital admission were higher in children less than 5 years of age. Incidence per 100,000 person-years was particularly high for infants aged 2 months to below 6 months of age (1762) but lower in those below two months

of age (627). Overall these estimates are higher than our previous 1997–1998 estimates but similar BGJ398 clinical trial to other Hong Kong estimates. Although a higher positivity rate for influenza was noted during the 2009/10 influenza surveillance period when A(H1N1)pdm09 started to circulate, this could reflect a permissive admission policy rather than increased disease burden and/or severity. Our data support the recommendation that effective vaccination of pregnant women is likely to have a significant impact on reducing disease burden in young infants below 6 months of age hospitalised for influenza. The Statistics and Workforce Planning Department in the Strategy and Planning Division of the Hong Non-specific serine/threonine protein kinase Kong Hospital Authority provided the paediatric hospitals admission dataset from the HA clinical data repository for this study. Contributors: All authors approved the manuscript. E.A.S.N., M.I., J.S.T., A.W.M., P.K.S.C., contributed to study design and data interpretation. M.I. was the principal investigator. L.A.S. undertook literature review and initial drafting of manuscript. E.A.S.N., S.L.C., M.I., S.K.L., W.G., contributed to data analysis and interpretation. E.A.S.N. wrote the manuscript and produced all figures. Funding: This study was funded by the World Health Organization as part of Project 49 of the United States of America Center for Disease Control and Prevention, Grant 5U50C1000748.